title: Systemic and regional therapy of advanced islet cell tumors.
abstract: Asymptomatic patients with islet cell tumors should be observed every 3 to 6 months. Once symptomatic, many therapeutic choices exist. First choice would be symptomatic management resulting in minimum side effects. More aggressive approaches include systemic therapy with cytotoxic or biologic agents. Vascular occlusion provides useful palliation of liver metastases.
authors.affiliation: Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
authors.forename: J A
authors.initials: JA
authors.lastname: Ajani
authors.forename: B
authors.initials: B
authors.lastname: Levin
authors.forename: S
authors.initials: S
authors.lastname: Wallace
mesh_terms: D007516:Adenoma, Islet Cell / Q000188:drug therapy* / Q000532:radiotherapy; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D004621:Embolization, Therapeutic; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy